Navigation Links
Ascension Orthopedics Granted Patent for PyroCarbon Humeral Head Design
Date:1/10/2011

AUSTIN, Texas, Jan. 10, 2011 /PRNewswire/ -- Ascension Orthopedics, Inc., a market leader in PyroCarbon orthopedic implants, announces the receipt of a European patent for a PyroCarbon humeral head design currently being developed as a component of the TITAN™ Modular Shoulder System released in September 2010.

Jerome Klawitter, Ph.D., Founder and Chief Science Officer of Ascension Orthopedics, commented, "I am very pleased our PyroCarbon humeral head hemi-arthroplasty has been patented. PyroCarbon has been shown to cause much less damage to cartilage and bone joint tissues than the Co-Cr metal alloy currently used for shoulder joint hemi-arthroplasty. A PyroCarbon humeral head replacement should extend the functional life of shoulder hemi-arthroplasty and result in improved patient outcomes.  Extensive design and testing has resulted in the development of a product which will soon be available for clinical use."

Klawitter pioneered efforts using PyroCarbon in the manufacture of mechanical heart valves. In the 1970's, his focus turned toward the design of PyroCarbon implants for the orthopedic market. His collaborative efforts with the Mayo Clinic lead to the founding of Ascension Orthopedics in 1992. Since the introduction in 2000 of the first PyroCarbon total joint replacement for the MCP joint of the hand, Ascension has been dedicated to building on the company's experience by successfully using PyroCarbon in both hemi and total joint arthroplasty applications."Our commitment to research with PyroCarbon is based on the material's enhanced wear resistance and biocompatibility against native bone and cartilage compared to metals and ceramics. Native joints have been shown to lubricate through the adsorption of surfactant to cartilage, providing boundary layer lubrication. Similarly, adsorption of surfactant onto graphitic surfaces aids in lubricating joints, offering favorable wear characteristics against native cartilage," added Klawitter.

Ascension Orthopedics is the world leader in PyroCarbon arthroplasty with over 35,000 PyroCarbon extremity joints implanted. Marketed devices include PyroCarbon implants for the hand, wrist, elbow, shoulder and foot. The company is continuing its research and development for the shoulder, with several new products launching in 2011. Ascension's mission is to transform extremities by developing state-of-the-art orthopedic products for the upper and lower limbs to help patients suffering from pain and dysfunction. Ascension Orthopedics sells products in the United States and more than 20 countries worldwide. For further information, please visit http://www.ascensionortho.com/.FOR INFORMATION CONTACT:Laura LatimerAscension Orthopedics, Inc.512-836-5001
'/>"/>

SOURCE Ascension Orthopedics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Ascension Orthopedics Implants PyroTITAN™ in France
2. Ascension Orthopedics Announces Implantation of the TITAN™ Modular Total Shoulder
3. Ascension Orthopedics Announces First Implantations of TITAN™ Modular Shoulder
4. Ascension Orthopedics Receives FDA Approval for TITAN™ Modular Total Shoulder System
5. Ascension Orthopedics Implants First PyroCarbon Shoulder Device in United Kingdom
6. Phreesia to Accelerate Growth with $16 Million Investment Led by Ascension Health Ventures
7. Ascension Orthopedics Hires Key Senior Executives
8. Orthopedics This Week Announces 2010 Best Spine Technology Award Winners
9. Two Amedica®/US Spine® Implant Products Receive Best New Technology Awards from Orthopedics This Week
10. Trinity Orthopedics Receives Patent Allowance for Sagittally Stable Spinal Fixation System
11. ICAP Ocean Tomo Offers for Sale IP Portfolio of Active Implants for Electromagnetic Bone and Tissue Regeneration in Orthopedics, Trauma, and Wound Care
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... February 9, 2016 ... heute den Abschluss eines Kooperationsvertrags mit 10x ... Lösungen in den Bereichen Next-Generation-Sequencing (NGS), Single-Cell-Biology ... ; Frankfurt Prime Standard: QIA) gab heute ... für die Entwicklung und Förderung umfassender Lösungen ...
(Date:2/9/2016)... ORLANDO, Florida , February 9, 2016 /PRNewswire/ ... QIA) today announced a collaboration with 10x Genomics ... sequencing (NGS), single-cell biology and bioinformatics. --> ... announced a collaboration with 10x Genomics to develop ... single-cell biology and bioinformatics. --> QIAGEN ...
(Date:2/9/2016)... -- Mast Therapeutics, Inc. (NYSE MKT: MSTX), a ... and heart failure, today announced that it intends to offer ... in an underwritten public offering.  The offering is subject to ... as to whether or when the offering may be completed, ... offering.   --> --> ...
Breaking Medicine Technology:
(Date:2/9/2016)... ... February 09, 2016 , ... METTLER TOLEDO has ... personnel have a basic understanding of the techniques they use so they can ... help them reduce waste and rework to create a leaner overall lab experience. ...
(Date:2/9/2016)... ... ... i2i Systems, an early innovator and developer of population health management technology, ... report, Population Health Management 2015: How Far Can Your Vendor Take You? , ... The latest KLAS Report, leveraging over 200 user interviews, shines a light on ...
(Date:2/8/2016)... ... 08, 2016 , ... Brenntag Specialties, Inc.(BSI) , is ... & Beverage and Dietary Supplement market segments across the western ... geographies east of the Rocky Mountains since 2012. Consistent performance in business ...
(Date:2/8/2016)... , ... February 08, 2016 , ... ... L top-load case packer for pouches, bags, and flow wrapped products at WestPack ... co-packers and specialty product manufacturers step up to semi-automatic or fully-automatic case packing ...
(Date:2/8/2016)... ... February 08, 2016 , ... Local insurance agency ... Venice, FL area, has initiated a fundraiser for a two year old little ... days after Christmas. To support this beautiful child who is facing life’s journey ...
Breaking Medicine News(10 mins):